首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 郑晓皎
2022
CA
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
FPHAR, 10.3389/fphar.2022.875549
CA
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
FPHAR, 10.3389/fphar.2022.875549
CA
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
FPHAR, 10.3389/fphar.2022.875549
CA
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
FPHAR, 10.3389/fphar.2022.875549
CA
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
FPHAR, 10.3389/fphar.2022.875549
CA
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
FPHAR, 10.3389/fphar.2022.875549
CA
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
FPHAR, 10.3389/fphar.2022.875549
CA
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
FPHAR, 10.3389/fphar.2022.875549
CA
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
FPHAR, 10.3389/fphar.2022.875549
CA
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
FPHAR, 10.3389/fphar.2022.875549
CA
The clinical and mechanistic roles of bile acids in depression, Alzheimer's disease, and stroke
PROTEOMICS, 10.1002/pmic.202100324
CA
Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in mice
Nat Commun, 10.1038/s41467-022-29589-7
点击查看热心肠日报解读
CA
Metabolomics Analysis on Obesity-Related Obstructive Sleep Apnea After Weight Loss Management: A Preliminary Study
FRONT ENDOCRINOL, 10.3389/fendo.2021.761547
2021
FA
Hyocholic acid species as novel biomarkers for metabolic disorders
Nat Commun, 10.1038/s41467-021-21744-w
点击查看热心肠日报解读
2020
FA
Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism
Cell Metab, 10.1016/j.cmet.2020.11.017
点击查看热心肠日报解读
CA
Targeting the alternative bile acid synthetic pathway for metabolic diseases
PROTEIN CELL, 10.1007/s13238-020-00804-9
点击查看热心肠日报解读
CA
Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
PROTEIN CELL, 10.1007/s13238-020-00748-0
点击查看热心肠日报解读
2018
FA
Calorie restriction and its impact on gut microbial composition and global metabolism
FRONT MED-PRC, 10.1007/s11684-018-0670-8
FA
Pediatric Obstructive Sleep Apnea is Associated With Changes in the Oral Microbiome and Urinary Metabolomics Profile: A Pilot Study
JCSM, 10.5664/jcsm.7336